Incidence, Risk Factors and Outcome of Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)
18 Years
N/A
Both
Non Small Cell Lung Cancer, Lung Cancer
Trial Information
Incidence, Risk Factors and Outcome of Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)
The development of an empyema following pneumonectomy is a devastating complication,
especially if associated with an underlying fistula. Whilst the perioperative mortality of
pneumonectomy overall is now less than 5%, this rises to around 25% when complicated by
empyema, and about 50% when associated with fistula. In addition, there is the morbidity and
social cost of long-term drainage, chronic sepsis and often multiple operations.
Inclusion Criteria:
- Pneumonectomy for NSCLC
Exclusion Criteria:
- Pneumonectomy for other reasons (infectious pathology, trauma, mesothelioma, ...)
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Overall survival
Outcome Description:
overall 5-year survival after empyema following pneumonectomy
Outcome Time Frame:
5 years from surgery
Safety Issue:
No
Principal Investigator
Paul De Leyn, PhD; MD
Investigator Role:
Study Director
Investigator Affiliation:
UZ Leuven, Dept. Thoracic Surgery
Authority:
Belgium: Ethics Committee
Study ID:
EMPY2013
NCT ID:
NCT01837186
Start Date:
January 2012
Completion Date:
March 2013
Related Keywords:
- Non Small Cell Lung Cancer
- Lung Cancer
- Surgery
- NSCLC
- Carcinoma, Non-Small-Cell Lung
- Empyema
- Lung Neoplasms
Name | Location |
|---|
